Hemostatic Gel Market

Hemostatic gel is used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.In recent years, global hemostatic gels have developed rapidly, with an average growth rate of around 7%.In 2018, global production of hemostatic gels was about 3.26 million pieces.In 2018, China accounted for about 3 percent of global sales.In the next five years, China's hemostatic gel products will continue to grow rapidly.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Baxter, J&J, CryoLife, Integra Life Sciences are major suppliers.These suppliers have mastered key technologies and patents, and have a fixed customer base, which has formed a monopoly situation in the market.The growth of the elderly population and the increasing prevalence of chronic diseases are the driving factors affecting the industry.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually led to surgery, which in turn spurred the development of the hemostatic gel industry.

Hemostatic Gel Market contains market size and forecasts of Hemostatic Gel in global, including the following market information:

Global Hemostatic Gel Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Hemostatic Gel Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Hemostatic Gel companies in 2021 (%)

The global Hemostatic Gel market was valued at 974.7 million in 2021 and is projected to reach US$ 1369.4 million by 2028, at a CAGR of 5.0% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Fibrin Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hemostatic Gel include Baxter, J&J, CryoLife, Integra Life Sciences, Advance Medical Solution, BD, CSL Behring, Pfizer and B Braun. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Hemostatic Gel manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hemostatic Gel Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hemostatic Gel Market Segment Percentages, by Type, 2021 (%)

Fibrin

Gelatin

Other

Global Hemostatic Gel Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hemostatic Gel Market Segment Percentages, by Application, 2021 (%)

Minimally Invasive Surgery

General Surgery

Others

Global Hemostatic Gel Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hemostatic Gel Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hemostatic Gel revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Hemostatic Gel revenues share in global market, 2021 (%)

Key companies Hemostatic Gel sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Hemostatic Gel sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Baxter

J&J

CryoLife

Integra Life Sciences

Advance Medical Solution

BD

CSL Behring

Pfizer

B Braun